Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B

BACKGROUND: Current treatments for chronic hepatitis B are suboptimal. In the search for improved therapies, we compared the efficacy and safety of pegylated interferon alfa plus lamivudine, pegylated interferon alfa without lamivudine, and lamivudine alone for the treatment of hepatitis B e antigen...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	George K.K. Lau, Teerha Piratvisuth, Xian Luo Kang, Patrick Marcellin, Satawat Thongsawat, Graham Cooksley, Edward Gane, Michael W. Fried, Cheng Chow Wan, Woon Paik Seung, Yu Chang Wen, Thomas Berg, Robert Flisiak, Philip McCloud, Nigel Pluck
التنسيق:	دورية
منشور في:	2018
الموضوعات:	Medicine
الوصول للمادة أونلاين:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=21244447705&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/62382
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
بواسطة: Lau G.K.K., وآخرون
منشور في: (2014)

THE DYNAMICS FOR ANTI-HBV INFECTION TREATMENT WITH PEGINTERFERON ALFA-2A
بواسطة: VIRA AKMERIANA (NIM: 10108054) ; Pembimbing : Dr. Nuning Nuraini,

Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B
بواسطة: Natthaya Chuaypen, وآخرون
منشور في: (2020)

Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b
بواسطة: Sunida Kuakarn, وآخرون
منشور في: (2018)

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
بواسطة: Jia Horng Kao, وآخرون
منشور في: (2018)

Hepatitis B virus gene mutations associated with HBeAg seroconversion
بواسطة: CHENG YAN
منشور في: (2010)

Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
بواسطة: Y. F. Liaw, وآخرون
منشور في: (2018)

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
بواسطة: Kao J., وآخرون
منشور في: (2017)

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
بواسطة: Hadziyannis, S.J., وآخرون
منشور في: (2011)

Vitamin D-binding protein gene polymorphism predicts pegylated interferon-related HBsAg seroclearance in HBeAg-negative Thai chronic hepatitis B patients: A multicentre study
بواسطة: Kessarin Thanapirom, وآخرون
منشور في: (2019)

Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study
بواسطة: Kessarin Thanapirom, وآخرون
منشور في: (2018)

Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study
بواسطة: Kessarin Thanapirom, وآخرون
منشور في: (2018)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
بواسطة: Phunchai Charatcharoenwitthaya, وآخرون
منشور في: (2018)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
بواسطة: Phunchai Charatcharoenwitthaya, وآخرون
منشور في: (2018)

Characteristics, prevalence, and HBeAg correlation of hepatitis B in pregnancy: A Siriraj Hospital experience
بواسطة: M. Thamkhantho, وآخرون
منشور في: (2020)

Maternal HBeAg positivity and viremia associated with umbilical cord blood hepatitis B viremia
بواسطة: Lee, L.Y., وآخرون
منشور في: (2022)

Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapy
بواسطة: Cheng, Y., وآخرون
منشور في: (2016)

Controversies in Treating Chronic HBV: The Role of PEG-interferon-alfa
بواسطة: Phunchai Charatcharoenwitthaya, وآخرون
منشور في: (2022)

Analisis Kadar HBeAg dan DNA VHB Pada Penderita Dengan HBsAg Positip
بواسطة: Mochamad Amin Soetjipto, -, وآخرون
منشور في: (2009)

Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand
بواسطة: Somsak Lolekha, وآخرون
منشور في: (2018)

Reversed passive hemagglutination test fails to detect HBsAg in a number of HBeAg positive sera
بواسطة: Duangtawan Thammanichanond, وآخرون
منشور في: (2018)

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
بواسطة: Narisa Tantai, وآخرون
منشور في: (2017)

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
بواسطة: Narisa Tantai, وآخرون
منشور في: (2018)

Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study
بواسطة: Thanapirom K., وآخرون
منشور في: (2017)

A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B
بواسطة: Lim, S.G., وآخرون
منشور في: (2012)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
بواسطة: Charatcharoenwitthaya P., وآخرون
منشور في: (2017)

STATUS SEROLOGI HBeAg PADA PASIEN INFEKSI VIRUS HEPATITIS B (VHB) KRONIS DI RSUD DR. SOETOMO SURABAYA
بواسطة: Kartika Wensdi Renantriandani, NIM011411131127
منشور في: (2017)

Association of Liver Fibrosis based on Transient Elastography and Quantitative HBsAg Levels in HBeAg-Positive Chronic Hepatitis B Patients
بواسطة: Titong Sugihartono, -, وآخرون
منشور في: (2020)

Association of Liver Fibrosis based on Transient Elastography and Quantitative HbsAg Levels in HBeAg-Positive Chronic Hepatitis B Patients
بواسطة: Titong Sugihartono, وآخرون
منشور في: (2020)

Proportion of HBsAg and HBeAg Positive in Maternal Patients and Their HBsAg Positives Babies with Immunoprophylaxis of HBVImmunization in Dr. Soetomo General Hospital, Surabaya
بواسطة: Melina Rosita Tanadi, وآخرون
منشور في: (2017)

Hubungan antara Fibrosis Hati Berdasarkan Pemeriksaan Fibroscan dengan Kadar HBsAg Kuantitatif pada Pasien Hepatitis B Kronis HBeAg (+)
بواسطة: Debrina Kusuma Devi
منشور في: (2020)

Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens
بواسطة: D. Pongpipat, وآخرون
منشور في: (2018)

Telbivudine versus lamivudine in patients with chronic hepatitis B
بواسطة: Ching Lung Lai, وآخرون
منشور في: (2018)

HUBUNGAN ANTARA HBsAg KUANTITATIF DAN HBeAg KUALITATIF IBU DENGAN INFEKSI VIRUS HEPATITIS B PLASENTA PADA IBU HAMIL DENGAN HEPATITIS B
بواسطة: Cahyanti Nugraheni, dr
منشور في: (2017)

Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg
بواسطة: D. Pongpipat, وآخرون
منشور في: (2018)

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden
بواسطة: Satawat Thongsawat, وآخرون
منشور في: (2018)

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden
بواسطة: Satawat Thongsawat, وآخرون
منشور في: (2018)

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden
بواسطة: Satawat Thongsawat, وآخرون
منشور في: (2018)

PERBANDINGAN ANTARA NILAI HBsAg KUANTITATIF DAN HBeAg IBU TERHADAP HBsAg BAYI PADA IBU HAMIL HEPATITIS B YANG DILAKUKAN PERSALINAN SEKSIO SESARIA DAN PERVAGINAM
بواسطة: Dibya Arfianda, dr, NIM011228086303
منشور في: (2018)

Lamivudine (3-TC)
بواسطة: จิราภรณ์ อังวิทยาธร
منشور في: (2020)